Self, Wesley H, et al. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, Oxford University Press, 13 Sept. 2019.
Piktel, Ewelina, et al. International Journal of Molecular Sciences, 25 August 2018
Ordija, Christine M, et al. American Journal of Physiology. Lung Cellular and Molecular Physiology, American Physiological Society, 1 June 2017.
Jain, Seema, et al. The New England Journal of Medicine, U.S. National Library of Medicine, 30 July 2015.
Community-Acquired Pneumonia Requiring Hospitalization Among U.S. Adults Read More »
Dr. Lester Kobzik, Professor of Medicine, Harvard T.H. Chan School of Public Health Publishes: Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. This major plasma gelsolin advancement was published in May in Journal of American Physiology—Lung, Cellular and Molecular Physiology. Read article here.
Yang, Zhiping, et al. American Journal of Physiology. Lung Cellular and Molecular Physiology, American Physiological Society, 1 July 2015.
Company Enters into Collaborative Research Agreement with NIAID and Company to Run Phase 2a/b Trials in EU BioAegis Therapeutics Inc., a privately held biotechnology company commercializing plasma gelsolin (pGSN), an endogenous human protein that simultaneously modulates inflammation and boosts immune function announced that its recently closed convertible note round was oversubscribed by investors. Read article
Li, H, et al. SAGE Journals, 11 October 2013.
Li-feng Huang, Yong-ming Yao, et al. PLOS ONE, Public Library of Science. 1 November, 2011
Lee, Po-Shun, et al. Journal of the American Society of Nephrology : JASN, American Society of Nephrology, May 2009.
Plasma Gelsolin and Circulating Actin Correlate with Hemodialysis Mortality. Read More »